Occult systemic non-Hodgkin's lymphoma (NHL) in patients initially diagnosed as primary central nervous system lymphoma (PCNSL): how much staging is enough?
about
A systematic approach to the diagnosis of suspected central nervous system lymphoma.18F-FDG PET in the diagnosis and treatment of primary central nervous system lymphoma.Quiescent nasal T/NK cell lymphoma manifested as primary central nervous system lymphoma.Treatment options for central nervous system lymphomas in immunocompetent patients.The utility of body FDG PET in staging primary central nervous system lymphomaAge-incidence patterns of primary CNS tumors in children, adolescents, and adults in England.Diagnosis and management of primary intraocular lymphoma: an updatePresent and future treatment options for primary CNS lymphoma.Unusual relapse of primary central nervous system lymphoma.Clinical characteristics and outcome of isolated extracerebral relapses of primary central nervous system lymphoma: a case series.18F-FDG PET/CT in primary brain lymphoma.Testicular relapse of primary central nervous system lymphoma.Late relapse of primary central nervous system lymphoma.Diffusional kurtosis imaging for differentiating between high-grade glioma and primary central nervous system lymphoma.Importance of complete staging in non-Hodgkin's lymphoma presenting as a cerebral mass lesion.The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis.Incidence, clinical features, treatment and outcome of primary central nervous system lymphoma in Norway.
P2860
Q30586022-DF46D4AE-F2E3-42FA-906C-DF59816BDE2BQ30654615-9E8C9B10-4320-4FED-98A0-DB22763441B8Q31917410-547A3677-24A1-4F40-AC13-68D90B77AB72Q33510785-74A2C3E3-1549-468A-9ED3-8780BE273637Q37036944-D56C1F88-D32D-4A0E-9356-B1F6BF6A28DEQ37344955-3CE49C84-E384-43F7-BC5D-54FBBDC92F94Q37577405-5D097805-3409-49E8-A3D7-5451E91FC06FQ38587122-EB4E65C4-B606-42FC-8507-2C807C44BF30Q38850335-D6AF0443-5B74-4FEF-8855-A59B28F7A604Q44981700-D128CD61-51B7-4783-A74F-FE7728E651A9Q47576872-C9F8971B-B24E-4DF6-A0B1-3E0474F5E76CQ48175015-CFDE9068-C1C5-41D2-9900-35A2FAA2462BQ48631019-D5756D78-7447-4949-8E75-57F572357D0AQ48715142-F7F3CB85-3374-4142-B19D-E8ECE137A80CQ49106104-70F12900-8A18-43F2-A426-C442A29DFD9EQ50702620-464BC3AE-5614-44A6-8866-9C6AF93EF9B0Q50748905-ABBDABB7-3758-4503-B368-F6A4A101517B
P2860
Occult systemic non-Hodgkin's lymphoma (NHL) in patients initially diagnosed as primary central nervous system lymphoma (PCNSL): how much staging is enough?
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Occult systemic non-Hodgkin's ...... ): how much staging is enough?
@en
type
label
Occult systemic non-Hodgkin's ...... ): how much staging is enough?
@en
prefLabel
Occult systemic non-Hodgkin's ...... ): how much staging is enough?
@en
P2093
P356
P1476
Occult systemic non-Hodgkin's ...... ): how much staging is enough?
@en
P2093
B P O'Neill
P J Kurtin
R P Dinapoli
T M Habermann
P2888
P356
10.1007/BF01054724
P577
1995-01-01T00:00:00Z
P6179
1052627293